Prognostic significance of total disease length in esophageal cancer

Surgical Endoscopy

Volumn 26, Issue 10, 2012, Pages 2810-2816

  Davies, L ^a   Mason, J D ^a   Roberts, S A ^a   Chan, D ^a   Reid, T D ^a   Robinson, M ^b   Gwynne, S ^c   Crosby, T D ^c   Lewis, W G ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Esophageal cancer; Operative; Prognosis; Surgical procedures

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REDUCTION; ECHOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 84871611898     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-012-2250-3     Document Type: Article

References (30)

1. Cancer Research UK. www.cancerresearchuk.org. Accessed 22 Jan 2011
2. Yendamuri S, Swisher S, Correa A, Hofstetter W, Ajani J, Francis A, Maru D, Mehran R, Rice D, Roth J, Walsh G, Vaporciyan A (2009) Esophageal tumour length is independently associated with long-term survival. Cancer 115:508-516
3. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95(7):1434-1443
4. Bollschweiler E, Baldus S, Schroder W, Schneider P, Holscher A (2006) Staging of esophageal carcinoma: length of tumour and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol 94:355-363 (Pubitemid 44465337)
5. Griffiths E, Brummell Z, Gorthi G, Pritchard S, Welch I (2006) Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Sur Oncol 93:258-267 (Pubitemid 43329818)
6. Earlam R, Cunha-Melo J (1980) Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67(6): 381-390
7. Ma G, Rong T, Long H, Fu J, Lin P, Huang Z, Zeng C, Zhang X, Li X, Zhang L, Wen Z, Wang J, Zhang P, Hu Y, Zhu Z (2004) Shrinkage of resected specimens of oesophageal carcinoma [abstract]. Ai Zheng 23(2):193-195
8. Kennedy BJ (1987) The unified international gastric cancer staging classification. Scand J Gastroenterol 22(Suppl 133):11-13 (Pubitemid 17112503)
9. Weaver S, Blackshaw G, Lewis WG, Edwards P, Roberts SA, Thomas GV (2004) Comparison of special interest computerised tomography, endosonography and histopathological stage of oesophageal cancer. Clin Radiol 59:499-504 (Pubitemid 38735555)
10. Kawahara K, Maekawa T, Okabayashi K, Shiraishi T, Yoshinega Y, Yoneda S, Hideshima T, Shirakusa T (1998) The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 67:160-163 (Pubitemid 28134403)
11. Sobin LH, Gospodarowicz MK, Wittekind C (2009) UICC TNM classification of malignant tumors, 7th edn. Wiley, New York
12. Penman I, Norton S, Harris K (2004) Staging of oesophagogastric carcinoma by endoscopic ultrasonography: guidance and minimum standards. British Society of Gastroenterology [http://www.bsg.org.uk/clinical-guidance/endoscopy/guidance- for-endo scopic-ultrasonography-uk-eus-users-groups-.html] Accessed 31st March 2011
13. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727-1733
14. Blazeby JM, Metcalfe C, Nicklin J, Barham CP, Donovan J, Alderson D (2005) Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. Br J Surg 92(12):1502-1578
15. Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, Court J, Maughan TS (2005) Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 90:70-75
16. Rice PF, Crosby TL, Roberts SA (2003) Variability of the carinaincisor distance as assessed by endoscopic ultrasound. Clin Oncol (R Coll Radiol) 15(7):383-385 (Pubitemid 37161701)
17. Twine CP, Roberts SA, Rawlinson CE, Davies L, Escofet X, Dave BV, Crosby TD, Lewis WG (2010) Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer. Dis Esophagus 23(8):652-659
18. Twine CP, Roberts SA, Lewis WG, Dave BV, Rawlinson CW, Chan D, Robinson M, Crosby TD (2010) Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer. Surg Endosc 24(4):870-878
19. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ (1998) Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115(3):660-669
20. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V (2006) The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on cancer staging system. J Thorac Cardiovasc Surg 132(6):1374-1381
21. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z (2006) The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-1025
22. Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247(2):365-371 (Pubitemid 351156783)
23. Tachibana M, Yoshimura H, Kinugasa S, Dhar DK, Shibakita M, Ohno S (2001) Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Dig Liver Dis 33(7):534-538 (Pubitemid 32994624)
24. Morgan MA, Lewis WG, Crosby TD, Escofet X, Roberts SA, Brewster AE, Havard TJ, Clark GW (2007) Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer. Br J Surg 94(12): 1509-1514 (Pubitemid 350275630)
25. Lewis I (1946) The surgical treatment of carcinoma of the oesophagus, with special reference to new operation for growths of middle third. Br J Surg 34:18-31
26. Tanner IC (1947) The present position of carcinoma of the oesophagus. Postgrad Med J 23:109-139
27. Orringer MB (1984) Transhiatal oesophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 200: 282-288
28. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 58:457-481
29. Cox DR (1972) Regression models and life tables. J R Stat Soc B:187-200
30. Siu KF, Cheung HC, Wong J (1986) Shrinkage of the esophagus after resection for carcinoma. Ann Surg 203(2):173-176 (Pubitemid 16144705)